X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (424) 424
Patent (94) 94
Book Review (20) 20
Conference Proceeding (17) 17
Publication (14) 14
Book / eBook (9) 9
Book Chapter (5) 5
Magazine Article (3) 3
Dissertation (2) 2
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (211) 211
humans (184) 184
male (138) 138
female (133) 133
gastroenterology & hepatology (127) 127
middle aged (123) 123
adult (110) 110
chemistry (82) 82
metallurgy (82) 82
antiviral agents - therapeutic use (80) 80
hepatitis c (68) 68
aged (66) 66
treatment outcome (66) 66
gastroenterology and hepatology (64) 64
drug therapy, combination (58) 58
genotype (58) 58
hepatitis (58) 58
hepatitis c virus (58) 58
health aspects (56) 56
ribavirin (55) 55
hepatitis c, chronic - drug therapy (54) 54
abridged index medicus (53) 53
hepacivirus - genetics (49) 49
antiviral agents - adverse effects (48) 48
hepatitis b (48) 48
care and treatment (44) 44
liver cirrhosis (44) 44
interferon (43) 43
analysis (41) 41
cirrhosis (41) 41
hepatitis b, chronic - drug therapy (37) 37
liver (36) 36
therapy (36) 36
young adult (36) 36
clinical trials (35) 35
drug therapy (35) 35
surgery (35) 35
transplantation (34) 34
genetic aspects (33) 33
antiviral agents - administration & dosage (32) 32
compounds of the metals beryllium, magnesium, aluminium,calcium, strontium, barium, radium, thorium, or of therare-earth metals (32) 32
inorganic chemistry (32) 32
sofosbuvir (32) 32
lamivudine (31) 31
liver transplantation (31) 31
adhesives (30) 30
chemical paint or ink removers (30) 30
coating compositions, e.g. paints, varnishes orlacquers (30) 30
correcting fluids (30) 30
dyes (30) 30
filling pastes (30) 30
impregnating or coating of paper (30) 30
indexing scheme relating to structural and physical aspects ofsolid inorganic compounds (30) 30
inks (30) 30
miscellaneous applications of materials (30) 30
miscellaneous compositions (30) 30
natural resins (30) 30
paints (30) 30
paper (30) 30
paper not otherwise provided for (30) 30
paper-making (30) 30
pastes or solids for colouring or printing (30) 30
polishes (30) 30
preparation of carbon black (30) 30
preparation thereof not covered by subclasses d21c or d21d (30) 30
production of cellulose (30) 30
pulp compositions (30) 30
textiles (30) 30
treatment of finished paper not covered by class b31 or subclass d21g (30) 30
treatment of inorganic materials, other than fibrous fillers,to enhance their pigmenting or filling properties (30) 30
treatment of water, waste water, sewage, or sludge (30) 30
use of materials therefor (30) 30
woodstains (30) 30
human necessities (29) 29
hygiene (29) 29
medical or veterinary science (29) 29
preparations for medical, dental, or toilet purposes (29) 29
viral load (29) 29
adolescent (28) 28
double-blind method (28) 28
medicine, general & internal (28) 28
patients (28) 28
antiviral agents (27) 27
ribavirin - therapeutic use (27) 27
hepatocellular-carcinoma (26) 26
infection (26) 26
time factors (26) 26
research (25) 25
infections (24) 24
hepacivirus - drug effects (23) 23
microbiology (23) 23
peptides (23) 23
disease (22) 22
hepatitis c - drug therapy (22) 22
organic chemistry (22) 22
risk factors (22) 22
hcv (21) 21
adefovir dipivoxil (20) 20
biological response modifiers (20) 20
genotype & phenotype (20) 20
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (3) 3
UTL at Downsview - May be requested (2) 2
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Stacks (1) 1
OISE - Children's Literature (1) 1
OISE - Storage (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (509) 509
French (25) 25
Korean (16) 16
German (15) 15
Spanish (11) 11
Chinese (6) 6
Polish (4) 4
Portuguese (4) 4
Slovenian (4) 4
Croatian (3) 3
Danish (3) 3
Hungarian (3) 3
Serbian (2) 2
Greek (1) 1
Italian (1) 1
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9973, pp. 1075 - 1086
Summary Background There is a high medical need for an interferon-free, all-oral, short-duration therapy for hepatitis C virus (HCV) that is highly effective... 
Internal Medicine | SUSTAINED VIROLOGICAL RESPONSE | MEDICINE, GENERAL & INTERNAL | PLUS RIBAVIRIN | HCV NS5A INHIBITOR | SOFOSBUVIR | TREATMENT-EXPERIENCED PATIENTS | DISEASE BURDEN | DOUBLE-BLIND | SIMEPREVIR | INTERFERON-ALPHA 2A | TREATMENT-NAIVE PATIENTS | Humans | Middle Aged | Hepacivirus - genetics | Imidazoles - administration & dosage | Benzofurans - administration & dosage | Male | RNA, Viral - blood | Interferons - therapeutic use | Hepatitis C, Chronic - complications | Polyethylene Glycols - therapeutic use | Viral Load | Young Adult | Ribavirin - administration & dosage | Treatment Failure | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Liver Cirrhosis - etiology | Drug Administration Schedule | Quinoxalines - administration & dosage | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Adolescent | Aged | Medical colleges | Protease inhibitors | Proteases | Clinical trials | Product development | Biological response modifiers | Hepatitis C virus | Health aspects | Liver cirrhosis | Ribavirin | Comparative studies | Hepatitis | Genotype & phenotype | Interferon | Drug therapy | Index Medicus | Abridged Index Medicus | Life Sciences | Infectious Medicine | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Infektionsmedicin
Journal Article
Gastroenterology, ISSN 0016-5085, 09/2017, Volume 153, Issue 3, p. 867
Journal Article
Gastroenterology, ISSN 0016-5085, 09/2017, Volume 153, Issue 3, p. 867
Journal Article
Gastroenterology, ISSN 0016-5085, 09/2017, Volume 153, Issue 3, p. 867
Journal Article
Gastroenterology, ISSN 0016-5085, 09/2017, Volume 153, Issue 3, pp. 867 - 867
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9865, pp. 468 - 475
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 4, pp. 354 - 369
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 685 - 697
Journal Article
Hepatology, ISSN 0270-9139, 10/2017, Volume 66, Issue 4, pp. 1023 - 1025
Journal Article
Internal medicine journal, ISSN 1444-0903, 03/2019
Hepatocellular carcinoma (HCC) is the most rapidly increasing cause of cancer mortality in New Zealand due to endemic Hepatitis B (HBV) infection and recent... 
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 2013, Volume 369, Issue 7, pp. 678 - 679
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9751, pp. 1467 - 1475
Journal Article
Gastroenterology, 09/2017, Volume 153, Issue 3, p. 867
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 1, pp. 34 - 44
In this small, preliminary study of sofosbuvir, a nucleotide inhibitor of HCV polymerase, treatment with sofosbuvir and ribavirin, without peginterferon, was... 
GENOTYPE 1 | PSI-7977 | MEDICINE, GENERAL & INTERNAL | VIRUS-INFECTION | THERAPY | REPLICATION | RESISTANCE | REPLICON RNA-SYNTHESIS | COMBINATION | TREATMENT-NAIVE PATIENTS | PROTEASE | Recombinant Proteins - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Adult | Female | RNA, Viral - metabolism | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - isolation & purification | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Hemoglobins - metabolism | Genotype | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Interferon-alpha - adverse effects | Viral Nonstructural Proteins - antagonists & inhibitors | Sofosbuvir | Drugs | Dose-response relationship (Biochemistry) | Antiviral agents | Usage | Patient outcomes | Dosage and administration | Product/Service Evaluations | Drug therapy, Combination | Hepatitis C | Drug therapy | Ribavirin | Hepatitis | Interferon | Infections | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 27, pp. 2608 - 2617
Journal Article